MyMD Announces 15 Million Offering with Existing Investors
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
BALTIMORE, February 21, 2023--MyMD Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases, today announced that it has executed a securities purchase agreement to raise gross proceeds of approximately 15 million in a registered direct offering of convertible preferred stock and warrants with certain accredited and institution
Read at finance.yahoo.com
 |
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
MYMD Old is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| UBX | Unity Biotechnology | 34.59 | ||||
| NBY | NovaBay Pharmaceuticals | 9.37 | ||||
| PASG | Passage Bio | 1.52 | ||||
| GOVX | GeoVax Labs | 1.36 | ||||
| KZR | Kezar Life | 1.06 | ||||
| AVIR | Atea Pharmaceuticals | 2.10 | ||||
| KROS | Keros Therapeutics | 2.22 | ||||
| KRON | Kronos Bio | 3.03 | ||||
| LRMR | Larimar Therapeutics | 3.43 | ||||
| LGND | Ligand Pharmaceuticals | 3.89 | ||||
| REPL | Replimune | 4.08 | ||||
| RXRX | Recursion Pharmaceuticals | 5.23 | ||||
| BOLT | Bolt Biotherapeutics | 5.26 | ||||
| XBIO | Xenetic Biosciences | 5.39 | ||||
| NVCT | Nuvectis Pharma | 5.83 | ||||
| ORIC | Oric Pharmaceuticals | 6.35 | ||||
| GOSS | Gossamer Bio | 7.62 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| LYRA | Lyra Therapeutics | 9.09 | ||||
| DSGN | Design Therapeutics | 11.02 | ||||
| SRZN | Surrozen | 12.96 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |